British drug major AstraZeneca Plc.'s COVID-19 vaccine, co-developed by the University of Oxford, has been approved for emergency supply in the UK.
The company is releasing the first doses today so that vaccinations may begin early in the New Year. AstraZeneca aims to supply millions of doses in the first quarter as part of an agreement with the government to supply up to 100 million doses in total.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.